MTOR and hepatocellular carcinoma: The m6A-modified circMDK regulated the miR-346/miR-874-3p-ATG16L1 axis, activating the PI3K/AKT/mTOR signaling pathway and eventually accelerating the process of HCC carcinogenesis (18).